Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Samuel C. Markson"'
Autor:
Sanjay M. Prakadan, Christopher A. Alvarez-Breckenridge, Samuel C. Markson, Albert E. Kim, Robert H. Klein, Naema Nayyar, Andrew W. Navia, Benjamin M. Kuter, Kellie E. Kolb, Ivanna Bihun, Joana L. Mora, Mia Solana Bertalan, Brian Shaw, Michael White, Alexander Kaplan, Jackson H. Stocking, Marc H. Wadsworth, Eudocia Q. Lee, Ugonma Chukwueke, Nancy Wang, Megha Subramanian, Denisse Rotem, Daniel P. Cahill, Viktor A. Adalsteinsson, Jeffrey W. Miller, Ryan J. Sullivan, Scott L. Carter, Priscilla K. Brastianos, Alex K. Shalek
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-10 (2021)
Leptomeningeal disease (LMD) is a serious complication of metastatic solid tumors with a poor prognosis. Here, by using single-cell RNA sequencing of cerebrospinal fluid, the authors report genomic and immune correlates of response to immunotherapy i
Externí odkaz:
https://doaj.org/article/687017c072604770afffff35e85435f2
Autor:
Sanjay M. Prakadan, Christopher A. Alvarez-Breckenridge, Samuel C. Markson, Albert E. Kim, Robert H. Klein, Naema Nayyar, Andrew W. Navia, Benjamin M. Kuter, Kellie E. Kolb, Ivanna Bihun, Joana L. Mora, Mia Solana Bertalan, Brian Shaw, Michael White, Alexander Kaplan, Jackson H. Stocking, Marc H. Wadsworth, Eudocia Q. Lee, Ugonma Chukwueke, Nancy Wang, Megha Subramanian, Denisse Rotem, Daniel P. Cahill, Viktor A. Adalsteinsson, Jeffrey W. Miller, Ryan J. Sullivan, Scott L. Carter, Priscilla K. Brastianos, Alex K. Shalek
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-1 (2021)
Externí odkaz:
https://doaj.org/article/1614fb2814784904ac0256c7d01e340d
Publikováno v:
Trends in Immunology. 44:326-328
Autor:
Scott L. Carter, Priscilla K. Brastianos, Ryan J. Sullivan, Mario L. Suvà, Arlene H. Sharpe, Michael A. Davies, Benjamin Izar, Genevieve Marie Boland, Daniel P. Cahill, Bob Carter, William T. Curry, Brian V. Nahed, Elizabeth Gerstner, Nancy Wang, Matthew Frosch, Maria Martinez-Lage, McKenzie Shaw, Christine Hebert, Dennie T. Frederick, Brian C. Miller, Kristen E. Pauken, Osmaan Shahid, Michael White, Husain Danish, Swaminathan Kumar, Aarushi Jain, Megha Subramanian, Alexander Kaplan, Brian Shaw, Mia Bertalan, Corey M. Gill, Benjamin M. Kuter, Robert H. Klein, Andrew W. Navia, Joana L. Mora, Juliana M. Larson, Ashish Dahal, Magali de Sauvage, Albert E. Kim, Matthew R. Strickland, Matt Lastrapes, Naema Nayyar, Jackson H. Stocking, Samuel C. Markson, Christopher Alvarez-Breckenridge
Melanoma-derived brain metastases (MBM) represent an unmet clinical need because central nervous system progression is frequently an end stage of the disease. Immune checkpoint inhibitors (ICI) provide a clinical opportunity against MBM; however, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00f17c2d9eaeb2bd5b784cdd4cccee44
https://doi.org/10.1158/2326-6066.c.6550955.v1
https://doi.org/10.1158/2326-6066.c.6550955.v1
Autor:
Scott L. Carter, Priscilla K. Brastianos, Ryan J. Sullivan, Mario L. Suvà, Arlene H. Sharpe, Michael A. Davies, Benjamin Izar, Genevieve Marie Boland, Daniel P. Cahill, Bob Carter, William T. Curry, Brian V. Nahed, Elizabeth Gerstner, Nancy Wang, Matthew Frosch, Maria Martinez-Lage, McKenzie Shaw, Christine Hebert, Dennie T. Frederick, Brian C. Miller, Kristen E. Pauken, Osmaan Shahid, Michael White, Husain Danish, Swaminathan Kumar, Aarushi Jain, Megha Subramanian, Alexander Kaplan, Brian Shaw, Mia Bertalan, Corey M. Gill, Benjamin M. Kuter, Robert H. Klein, Andrew W. Navia, Joana L. Mora, Juliana M. Larson, Ashish Dahal, Magali de Sauvage, Albert E. Kim, Matthew R. Strickland, Matt Lastrapes, Naema Nayyar, Jackson H. Stocking, Samuel C. Markson, Christopher Alvarez-Breckenridge
Supplementary Figure from Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::511e81039a40c6df92ccce5b50a7030e
https://doi.org/10.1158/2326-6066.22545491.v1
https://doi.org/10.1158/2326-6066.22545491.v1
Autor:
Scott L. Carter, Priscilla K. Brastianos, Ryan J. Sullivan, Mario L. Suvà, Arlene H. Sharpe, Michael A. Davies, Benjamin Izar, Genevieve Marie Boland, Daniel P. Cahill, Bob Carter, William T. Curry, Brian V. Nahed, Elizabeth Gerstner, Nancy Wang, Matthew Frosch, Maria Martinez-Lage, McKenzie Shaw, Christine Hebert, Dennie T. Frederick, Brian C. Miller, Kristen E. Pauken, Osmaan Shahid, Michael White, Husain Danish, Swaminathan Kumar, Aarushi Jain, Megha Subramanian, Alexander Kaplan, Brian Shaw, Mia Bertalan, Corey M. Gill, Benjamin M. Kuter, Robert H. Klein, Andrew W. Navia, Joana L. Mora, Juliana M. Larson, Ashish Dahal, Magali de Sauvage, Albert E. Kim, Matthew R. Strickland, Matt Lastrapes, Naema Nayyar, Jackson H. Stocking, Samuel C. Markson, Christopher Alvarez-Breckenridge
Supplementary Data from Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0df63ea6b992a9c1526e21ec65ba3323
https://doi.org/10.1158/2326-6066.22545509
https://doi.org/10.1158/2326-6066.22545509
Autor:
Christopher Alvarez-Breckenridge, Samuel C. Markson, Jackson H. Stocking, Naema Nayyar, Matt Lastrapes, Matthew R. Strickland, Albert E. Kim, Magali de Sauvage, Ashish Dahal, Juliana M. Larson, Joana L. Mora, Andrew W. Navia, Robert H. Klein, Benjamin M. Kuter, Corey M. Gill, Mia Bertalan, Brian Shaw, Alexander Kaplan, Megha Subramanian, Aarushi Jain, Swaminathan Kumar, Husain Danish, Michael White, Osmaan Shahid, Kristen E. Pauken, Brian C. Miller, Dennie T. Frederick, Christine Hebert, McKenzie Shaw, Maria Martinez-Lage, Matthew Frosch, Nancy Wang, Elizabeth Gerstner, Brian V. Nahed, William T. Curry, Bob Carter, Daniel P. Cahill, Genevieve Marie Boland, Benjamin Izar, Michael A. Davies, Arlene H. Sharpe, Mario L. Suvà, Ryan J. Sullivan, Priscilla K. Brastianos, Scott L. Carter
Publikováno v:
Cancer Immunol Res
Melanoma-derived brain metastases (MBM) represent an unmet clinical need because central nervous system progression is frequently an end stage of the disease. Immune checkpoint inhibitors (ICI) provide a clinical opportunity against MBM; however, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20edbdce0d8007b51c4ae75d9cb53333
https://europepmc.org/articles/PMC10201927/
https://europepmc.org/articles/PMC10201927/